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orescence staining and qRT-PCR.
RESULTS After oral administration, aspirin could effectively inhibit
platelet P-selectin (CD62P) expression and the ratio of TXB2 and 6-
keto-PGF1a in control group, but failed to take effect in HFD/STZ-
induced diabetic mice. The SA concentration in HFD/STZ-induced
diabetic mice was still signiﬁcantly higher than that in normal mice.
Immunohistochemical analysis revealed an decreased expression of
COX-2 in the HFD/STZ-induced diabetic mice by the aspirin treatment.
Compared with control group, the mRNA levels for renal OAT1, OAT2
and SMCT1 were unanimously down-regulated in HFD/STZ-induced
diabetic mice, in accordance with the pathological changes of kidney.
CONCLUSIONS Our study reports the novel ﬁnding that SA accumula-
tion ;renders AR via breaking the balance of the innate COX-1/COX-2
function in HFD/STZ-induced diabetic mouse model. The mechanism of
SA accumulation is largely attributed to the down-regulation of renal
transporter function and acidic environment in the diabetic state.
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OBJECTIVES Both the CHADS2 and CHA2DS2-VASc scores are well-
validated for predicting risk of stroke among patients with atrial ﬁbril-
lation (AF), but most validation studies have been in Western
populations. Some uncertainty is evident for the selection of which score
to guide optimal anticoagulant therapy among Asian populations with
AF. We aimed to perform a systemic review and meta-analysis of avail-
able studies to compare CHADS2 and CHA2DS2-VASc scores for risk
stratiﬁcation and second, to establish which score has a better perfor-
mance in identifying ‘truly low risk’ AF patients from Asia.
METHODS A systemic literature search of Cochrane library, Scopus,
and PubMed databases was conducted using search terms including
atrial ﬁbrillation, CHADS2 and CHA2DS2-VASc. Stroke / thromboem-
bolism outcome events at low, moderate, and high risk groups were
compared in relation to both scores. Statistical analyses were per-
formed using Revman 5.3 software.
RESULTS 493 records were retrieved, of which 6 cohort studies focusing
on non-anticoagulated patients from Asian regions were appraised and
included. Absolute event rates were usually lower when patients were
categorized as CHA2DS2-VASc of 0-1, rather than CHADS2 of 0-1, respec-
tively. Meta-analysis revealed that when compared with the CHA2DS2-
VASc score, there was a 1.71-fold (95% conﬁdence intervals (CI): 1.26-2.31)
elevated risk of stroke when patients were stratiﬁed as ‘low risk’ using a
CHADS2 score¼0, or a 1.40-fold (95%CI: 1.20-1.64) increase with a
CHADS2score¼1. A 1.19-fold (95%CI: 1.02-1.38) elevated risk was observed
amongst CHADS2 score 2, but the total number of events were higher
when patients were categorized as CHA2DS2-VASc 2.
CONCLUSIONS The CHA2DS2-VASc score is superior to the CHADS2
score in identifying ‘truly low risk’ Asians patients with AF. Rather
than a categorical (ie. low/moderate/high risk) approach, Asian
guidelines should adopt a 2 step approach, by initially identifying the
low risk patients (using the CHA2DS2-VASc score) who do not need any
thromboprophylaxis, following which effective stroke prevention can
be offered to those with 1 stroke risk factors.
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OBJECTIVES It was controversial that whether C-reactive protein
(CRP) was a prognostic marker in patients with acute myocardial
infarction (AMI). We undertook this meta-analysis to make it clear.
METHODS A systematic literature search was conducted using Med-
line, PubMed, and Web of Science for prospective studies of patientswith AMI that reported outcomes according to serum CRP levels. The
relationships between levels of CRP and prognoses were assessed.
RESULTS 10368 patients in 9 studies were identiﬁed. Long term
follow-up varied from 6 months to 10 years. Mean level of CRP was
8.79mg/L. High CRP levels were associated with higher mortality(odds
ratio, 2.40; 95% CI, 1.44 to 3.99; P<0.001) and more heart failure (odds
ratio, 2.08; 95% CI, 1.49 to 2.89; P<0.001). The risk of mortality
remained evident in subgroup analyses according to cut-off level of
CRP. For the cut-off level of 3 mg/L and 10mg/L, the odds ratios of
mortality were 2.69 (95% CI, 1.06 to 6.82, P ¼ 0.04) and 2.32 (95% CI,
1.18 to 4.55, P¼0.01), respectively.
CONCLUSIONS A high level of serum CRP was signiﬁcantly associated
with poor prognoses in patients with AMI.
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OBJECTIVES Cardiovascular autonomic neuropathy (CAN) is closely
associated with increased mortality in diabetic patients. Several risk
factors of CAN have been clearly clariﬁed. However, the impact of
cystatin C(Cys C) on CAN is still unclear. Therefore, this study aimed
to investigate the association between Cys C and CAN in newly
diagnosed type 2 diabetic patients with normal renal function and
urinary albumin excretion rate (UAER).
METHODS 90 newly diagnosed type 2 diabetic patients (58%male, mean
age: 48 years old) were enrolled. Heart rate variability (HRV) measured
by Holter were used to identify CAN. Cys C was measured by particle-
enhanced turbidimetric immunoassay (PETIA). Based on the results from
HRV, subjects were then further divided into two groups: diabetic pa-
tients with CAN (CANþ group) or without CAN (CAN- group).
RESULTS The positive rate of CAN in newly diagnosed type 2 diabetic
patients was 35.6%. Compared with CAN- group (n ¼58), CANþ group
(n ¼32) had signiﬁcantly higher Cys C (0.97 0.32 vs. 0.75  0.14 mg/L,
P¼0.02) but no signiﬁcant differences were observed in creatine, glycated
hemoglobin (HbA1c) or UAER between groups. Cys C was correlated with
SDNNINDEX (r ¼-0.38, P ¼0.04), Low frequency domain(LF) (r ¼-0.48,
P ¼0.008) and Highfrequency domain(HF) (r ¼-0.49, P ¼0.006). Logistic
regression analysis revealed that Cys C was an independent risk factor of
CAN in this population (OR:1.71, 95%CI:1.57w1.87, P ¼0.037) after
adjusting for creatine, HbA1c and systolic blood pressure.
CONCLUSIONS Prevalence of cardiovascular autonomic nerve is high
in newly diagnosed type 2 diabetic patients with normal renal func-
tion and UAER. Cys C is associated with CAN in this population.
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OBJECTIVES Oral anticoagulation (OAC, eg. warfarin) is effective for
stroke prevention in patients with atrial ﬁbrillation (AF), but underuse
of warfarin is common, and data on clinical features associated with
non-use in Asian countries are limited. The present study was per-
formed to provide insights into ‘real world’ OAC use in hospitalized
nonvalvular AF patients in the Nanchang AF Project.
METHODS We studied consecutive non-valvular AF patients admitted
to cardiovascular department in the second afﬁliated hospital of
Nanchang University between May 2011 and December 2013. Antith-
rombotic therapy use among AF patients were analyzed in relation to
age groups (<40 years, 40-64 years, 65-74 years, 75 years), and
CHA2DS2-VASc score strata (low risk (0 for male or 1 for female), 1 for
male, high risk ie. 2). Multivariate regression analysis was conducted
to evaluate the predictors of warfarin use.
RESULTS Among the 1453 NVAF patients, warfarin use before admission
was extremely low (9.4%) and increased to 44.7% during hospitalization.
The proportions of patients on warfarin decreased with age across the four
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36.7% in age75, respectively). Amongst high risk patients (CHA2DS2-VASc
score2), 45.1%patients receivedwarfarin after admission. Onmultivariate
analysis, predictors of warfarin use during hospital were hypertension (OR
[95%CI], 1.43 [1.14-1.79], P ¼0.002), the composite of previous stroke/
transient ischemic attack(TIA)/thromboembolism (TE) (OR[95%CI], 1.58
[1.17-2.14], P¼0.003), age75 years (OR[95%CI], 0.55 [0.43-0.69], P<0.001)
and coronary artery disease (OR[95%CI], 0.61 [0.47-0.80], P <0.001).
CONCLUSIONS Our ﬁndings show low OAC use in Chinese AF pop-
ulations, where age 75 years and coronary artery disease are nega-
tive predictors of warfarin use. Patients with hypertension or previous
stroke/TIA/TE are more often prescribed OAC.
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OBJECTIVES The status of sexual activity and sexual counseling for
patients after percutaneous coronary intervention (PCI) has not been
previously investigated in China. This study aims to evaluate the
current status of communication regarding sexual matters in China to
establish a platform for effective communication.
METHODS This study represents data from 198 patients who partici-
pated in a retrospective cross-sectional survey after PCI. Issues con-
cerning preoperative and postoperative sexual activity and sexual
counseling were investigated by telephone interview. After initial
questionnaire interviews, follow up telephone interviews were used
as a means to expand our data in a qualitative manner and better
understand patient responses.
RESULTS We investigated frequency of sexual activity, satisfaction and
factors inﬂuencing sexual activity after PCI, as well as patient percep-
tions of sexual counseling. 71.5% of the patients resumed sexual ac-
tivity after PCI, but decreases in frequency (43.7%) and satisfaction
(26.2%) appeared. Decreased satisfaction was associated with anxiety
about potential recurrent cardiac events and sudden death. 28.5% of
patients did not resume sexual activity primarily out anxiety or fear. A
relatively large number of patients did not discuss sex-related issues
after PCI with their partners (78.3%) or doctors (97.5%). Nonetheless,
72.1% of these patients considered it to be appropriate for doctors to
discuss sex-related issues with patients. Telephone follow-up (43%) or
private in person conversations were generally (40.3%) considered
acceptable for physician patient communication.
CONCLUSIONS Abnormal or unsatisfactory sexual activity following
PCI is prevalent exists in China, which results largely from the inef-
fectiveness of communication. Effective solutions must be sought to
help such post-PCI patients with rehabilitation of sexual activities.
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OBJECTIVES Transcatheter closure of paravalvular regur-
gitation(PVR) have been used with varying degrees of success, while
transapical closure of PVR only guided by echocardiography is highly
infrequent. We presented two cases of successful transapical closure
of PVR, and discussed the role of real time three dimensional echo-
cardipgraphy (RT-3D TEE).
METHODS The clinical and echocardiographic characteristics of the two
patients who diagnosed as PVR after mitral valve replacement of rheu-
matic heart disease by echocardiography in our hospital were analyzed
RESULTS One patient was 43 years-old woman (case 1) and another
was 52 years-old man(case 2), both of them had accepted mitral me-
chanical prosthetic valve replacement for many years and moderate to
server PVR was detected by echo.
Before the operation, RT-3D TEE not only provided the location and
shape of the paravalvular leak, but also measured the leak dimensions
exactly to offer the accurate closure-device size for the physicians.
The paravalvular leak of Case 1 was nearly-circle and the location was6 clock on the anatomic view. The paravalvular leak of case 2 wasn’t
revealed clearly by RT-3D TEE, whereas the location and shape of the
leak were demonstrated accurately by color RT-3D TEE.
During the operation, the echocardiography was not only used to
conﬁrm the apical puncture point, guide the passage of the guide wire
and catheter through the defect, but also evaluate the residual PVR
and the motion of the leaﬂets.
After the operation immediately, case 1 had mild residual PVR as
well as case 2 had trace residual PVR, meanwhile the closure-device
was stable and displayed clearly by 3D echocardiography.
CONCLUSIONS Echocardiography is not only the ﬁrst choice of the
diagnostic approach for PVR, but also pays a prominent role in guiding
the device closure and evaluating the therapy effect, especially the
RT-3D TEE in the transapical closure of PVR.
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OBJECTIVES Activation of Rho-A/Rho-kinase pathway found recently
is one of the pathogenic mechanisms on pulmonary hypertension. It is
necessary to evaluate the efﬁcacy of Rho-kinase inhibitor Fasudil for
the treatment of pulmonary hypertension based on principle of Meta-
analysis and trial sequential analysis.
METHODS All randomized controlled trials, were searched from Med-
line (via Pubmed.com), Embase, Cochrane Library, Web of science,
Chinese Biomedical Literature Database, Chinese National Knowledge
Infrastructure, Chinese Scientiﬁc Journal Database and Wanfang Med
Online Database up to January 2015. Literatures were searched through
the manual and computer criteria. Two reviews independently evalu-
ated studies and extracted data. The method of Jadad scale (5 score
totally) was used to evaluate the quality of trials, RevMan 5.2.3 and TSA
software were managed for data analysis. Relative risk and mean dif-
ference with 95% conﬁdence interval were performed with ﬁxed or
random effect models. The values of I2 from 0% to 50% was regarded as
“heterogeneity might not be important”; the values of I2 between 51%
and 75% was regarded as “moderate heterogeneity”; the values of
I2>75% was regarded as “substantial heterogeneity”.
RESULTS The total amount of 8 randomized controlled trials with low
bias risk (Jadad scale score3) was included. Based on Meta-analysis,
the experiment group had signiﬁcant improvement versus the control
group on overall efﬁciency rate (6 trials including 562 patients, sample
size of experimental group/control group¼281/281) with moderate
heterogeneity (Cochrane’s chi-square test: Chi2¼10.99, P¼0.05, I2¼55%;
test for overall effect: RR¼1.22, 95% CI 1.09 to 1.36, Z¼3.51, P¼0.0004),
which was conﬁrmed in trial sequential analysis because the cumula-
tive Z-curve crossed the monitoring boundaries (RRR¼20%, incidence
in control arm¼72.9%, estimate of I type error¼5%, power¼80%,
required information size¼670, OD¼50%). No sufﬁcient evidence
conﬁrmed that Fasudil was able to reduce systolic pulmonary artery
pressure (5 trials including 380 patients, sample size of experimental
group/control group¼190/190), for trial sequential analyses indicated
that neither the required information size nor monitoring boundary was
exceeded by the cumulative Z-curve (estimate of I type error¼5%,
power¼80%, required information size¼1733, OD¼100%).
CONCLUSIONS Rho-kinase inhibitor Fasudil has some positive effects
on overall efﬁciency rate for pulmonary hypertension. However, to
approve the efﬁcacy on systolic pulmonary artery pressure, multi-
central and rigorous designed randomized controlled trials are still
needed because of sample size limited.
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OBJECTIVES Fluid resuscitation plays a major role in the treatments
of shock. And sonography is readily practical and non-invasive mak-
ing it become a useful diagnostic method in critical care. In this study,
we observed the change of lung ultrasound B-lines in shock and
postoperated patients who admitted in ICU, in order to better un-
derstand the lung edema in the process of ﬂuid resuscitation.
